1x95: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1x95.png|left|200px]] | [[Image:1x95.png|left|200px]] | ||
{{STRUCTURE_1x95| PDB=1x95 | SCENE= }} | {{STRUCTURE_1x95| PDB=1x95 | SCENE= }} | ||
===solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug=== | ===solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug=== | ||
{{ABSTRACT_PUBMED_15317822}} | {{ABSTRACT_PUBMED_15317822}} | ||
==About this Structure== | ==About this Structure== | ||
Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X95 OCA]. | [[1x95]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X95 OCA]. | ||
[[Category: Dai, J.]] | [[Category: Dai, J.]] | ||
[[Category: Mistry, P.]] | [[Category: Mistry, P.]] | ||
Line 31: | Line 16: | ||
[[Category: Anticancer drug]] | [[Category: Anticancer drug]] | ||
[[Category: Ap-1]] | [[Category: Ap-1]] | ||
[[Category: Dna]] | |||
[[Category: Mln944]] | [[Category: Mln944]] | ||
[[Category: Novel dna binding]] | [[Category: Novel dna binding]] | ||
[[Category: Transcription inhibition]] | [[Category: Transcription inhibition]] | ||
Revision as of 15:07, 5 January 2013
solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drugsolution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug
Template:ABSTRACT PUBMED 15317822
About this StructureAbout this Structure
1x95 is a 2 chain structure. Full experimental information is available from OCA.